CRITERIA - Building clinical trial capability and capacity to grow the MTP sector
This project will address the constraint in the growth of MTP sector, particularly for conducting clinical trials, through the training of appropriately skilled and experienced workforce participants.
CRITERIA will recruit appropriately trained graduates and equipped them with job ready skills through training and a six-month internship with MTP companies. At least 20 graduates will be trained and given practical experience in conducting clinical trials.
Outcomes: ARCS have trained 52 graduates in all aspects of pharmaceutical medicine and clinical research through 44 training events. 40 graduates of the CRITERIA program now have jobs within the clinical trial industry.
| State | New South Wales |
| Consortium lead | ARCS Australia |
| Consortium members | QuintilesIMS Pty Ltd, Novotech Ltd, Clinical Network Services (CNS) Pty Ltd, PPD Australia Pty Ltd, George Clinical Pty Ltd, OnQ Recruitment Pty Ltd, Seerpharma Pty Ltd, Pharma to Market Pty Ltd, UNSW Sydney, SPHERE, University of Sydney, Monash University & St Vincent’s Hospital |
| MTPConnect grant | $250,000 |
| Industry contribution | $260,422 |
| Project duration | March 2018 - December 2019 (Finished) |
| Contact | Dr Shanny Dyer, ARCS Australia - shannydyer@arcs.com.au |
Visit ARCS Australia's website for more details and watch the video above to learn more about the CRITERIA program.
Twitter: ARCSAustralia | LinkedIn: ARCS Australia
Listen to theMTPConnect podcast to hear ARCS Australia CEO Dr Shanny Dyer and more at the 2019 ARCS Australia Conference in Sydney.